Results
|
101.
|
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours. [electronic resource] by
- Kerklaan, B Milojkovic
- Lolkema, M P J
- Devriese, L A
- Voest, E E
- Nol-Boekel, A
- Mergui-Roelvink, M
- Langenberg, M
- Mykulowycz, K
- Stoebenau, J
- Lane, S
- Legenne, P
- Wissel, P
- Smith, D A
- Giantonio, B J
- Schellens, J H M
- Witteveen, P O
Producer: 20151123
In:
British journal of cancer vol. 113
Availability: No items available.
|
|
102.
|
The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies. [electronic resource] by
- Cirkel, G A
- Weeber, F
- Bins, S
- Gadellaa-van Hooijdonk, C G M
- van Werkhoven, E
- Willems, S M
- van Stralen, M
- Veldhuis, W B
- Ubink, I
- Steeghs, N
- de Jonge, M J
- Langenberg, M H G
- Schellens, J H M
- Sleijfer, S
- Lolkema, M P
- Voest, E E
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
103.
|
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours. [electronic resource] by
- Lankheet, N A G
- Kloth, J S L
- Gadellaa-van Hooijdonk, C G M
- Cirkel, G A
- Mathijssen, R H J
- Lolkema, M P J K
- Schellens, J H M
- Voest, E E
- Sleijfer, S
- de Jonge, M J A
- Haanen, J B A G
- Beijnen, J H
- Huitema, A D R
- Steeghs, N
Producer: 20140715
In:
British journal of cancer vol. 110
Availability: No items available.
|
|
104.
|
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy. [electronic resource] by
- Lalisang, R I
- Erdkamp, F L G
- Rodenburg, C J
- Knibbeler-van Rossum, C T A M
- Nortier, J W R
- van Bochove, A
- Slee, P H Th J
- Voest, E E
- Wils, J A
- Wals, J
- Loosveld, O J L
- Smals, A E M
- Blijham, G H
- Tjan-Heijnen, V C G
- Schouten, H C
Producer: 20111024
In:
Breast cancer research and treatment vol. 128
Availability: No items available.
|
|
105.
|
Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients. [electronic resource] by
- van Waalwijk van Doorn-Khosrovani, S B
- Pisters-van Roy, A
- van Saase, L
- van der Graaff, M
- Gijzen, J
- Sleijfer, S
- Hoes, L R
- van Berge Henegouwen, J M
- van der Wijngaart, H
- van der Velden, D L
- van Werkhoven, E
- Retel, V P
- van Harten, W H
- Huitema, A D R
- Timmers, L
- Gelderblom, H
- Verheul, H M W
- Voest, E E
Producer: 20200612
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
106.
|
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs. [electronic resource] by
- van der Velden, D L
- Hoes, L R
- van der Wijngaart, H
- van Berge Henegouwen, J M
- van Werkhoven, E
- Roepman, P
- Schilsky, R L
- de Leng, W W J
- Huitema, A D R
- Nuijen, B
- Nederlof, P M
- van Herpen, C M L
- de Groot, D J A
- Devriese, L A
- Hoeben, A
- de Jonge, M J A
- Chalabi, M
- Smit, E F
- de Langen, A J
- Mehra, N
- Labots, M
- Kapiteijn, E
- Sleijfer, S
- Cuppen, E
- Verheul, H M W
- Gelderblom, H
- Voest, E E
Producer: 20191120
In:
Nature vol. 574
Availability: No items available.
|